Ascendis Pharma Stock Forecast - Relative Strength Index
| ASND Stock | USD 235.39 6.74 2.95% |
Ascendis Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Ascendis Pharma stock prices and determine the direction of Ascendis Pharma AS's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ascendis Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of Ascendis Pharma's stock price is about 61. This suggests that the stock is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Ascendis, making its price go up or down. Momentum 61
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter 0.1024 | EPS Estimate Current Year (3.33) | EPS Estimate Next Year 3.7507 | Wall Street Target Price 273.5357 | EPS Estimate Current Quarter (0.16) |
Using Ascendis Pharma hype-based prediction, you can estimate the value of Ascendis Pharma AS from the perspective of Ascendis Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Ascendis Pharma using Ascendis Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Ascendis using crowd psychology based on the activity and movement of Ascendis Pharma's stock price.
Ascendis Pharma Short Interest
A significant increase or decrease in Ascendis Pharma's short interest from the previous month could be a good indicator of investor sentiment towards Ascendis. Short interest can provide insight into the potential direction of Ascendis Pharma stock and how bullish or bearish investors feel about the market overall.
200 Day MA 188.6825 | Short Percent 0.0678 | Short Ratio 4.77 | Shares Short Prior Month 3.4 M | 50 Day MA 209.9854 |
Ascendis Relative Strength Index
Ascendis Pharma AS Hype to Price Pattern
Investor biases related to Ascendis Pharma's public news can be used to forecast risks associated with an investment in Ascendis. The trend in average sentiment can be used to explain how an investor holding Ascendis can time the market purely based on public headlines and social activities around Ascendis Pharma AS. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Ascendis Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Ascendis Pharma.
Ascendis Pharma Implied Volatility | 0.52 |
Ascendis Pharma's implied volatility exposes the market's sentiment of Ascendis Pharma AS stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Ascendis Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Ascendis Pharma stock will not fluctuate a lot when Ascendis Pharma's options are near their expiration.
Ascendis Pharma after-hype prediction price | USD 235.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Ascendis Pharma to cross-verify your projections. Prediction based on Rule 16 of the current Ascendis contract
Based on the Rule 16, the options market is currently suggesting that Ascendis Pharma AS will have an average daily up or down price movement of about 0.0325% per day over the life of the 2026-04-17 option contract. With Ascendis Pharma trading at USD 235.39, that is roughly USD 0.0765 . If you think that the market is fully incorporating Ascendis Pharma's daily price movement you should consider acquiring Ascendis Pharma AS options at the current volatility level of 0.52%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Ascendis Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Ascendis Pharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Ascendis Pharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Ascendis Pharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Ascendis Pharma's open interest, investors have to compare it to Ascendis Pharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Ascendis Pharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Ascendis. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Ascendis Pharma Additional Predictive Modules
Most predictive techniques to examine Ascendis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ascendis using various technical indicators. When you analyze Ascendis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 61.39 | 61.39 |
| Check Ascendis Pharma Volatility | Backtest Ascendis Pharma | Information Ratio |
Ascendis Pharma Trading Date Momentum
| On January 26 2026 Ascendis Pharma AS was traded for 235.39 at the closing time. The top price for the day was 238.84 and the lowest listed price was 228.46 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not affect price variability. The overall trading delta against the current closing price is 2.86% . |
| Compare Ascendis Pharma to competition |
Other Forecasting Options for Ascendis Pharma
For every potential investor in Ascendis, whether a beginner or expert, Ascendis Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ascendis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ascendis. Basic forecasting techniques help filter out the noise by identifying Ascendis Pharma's price trends.Ascendis Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ascendis Pharma stock to make a market-neutral strategy. Peer analysis of Ascendis Pharma could also be used in its relative valuation, which is a method of valuing Ascendis Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Ascendis Pharma Market Strength Events
Market strength indicators help investors to evaluate how Ascendis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascendis Pharma shares will generate the highest return on investment. By undertsting and applying Ascendis Pharma stock market strength indicators, traders can identify Ascendis Pharma AS entry and exit signals to maximize returns.
Ascendis Pharma Risk Indicators
The analysis of Ascendis Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ascendis Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ascendis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.96 | |||
| Semi Deviation | 2.09 | |||
| Standard Deviation | 2.53 | |||
| Variance | 6.38 | |||
| Downside Variance | 5.07 | |||
| Semi Variance | 4.39 | |||
| Expected Short fall | (2.25) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Ascendis Pharma
The number of cover stories for Ascendis Pharma depends on current market conditions and Ascendis Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ascendis Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ascendis Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Ascendis Pharma Short Properties
Ascendis Pharma's future price predictability will typically decrease when Ascendis Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ascendis Pharma AS often depends not only on the future outlook of the potential Ascendis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascendis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.9 M | |
| Cash And Short Term Investments | 559.5 M |
Check out Historical Fundamental Analysis of Ascendis Pharma to cross-verify your projections. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ascendis Pharma. If investors know Ascendis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ascendis Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.50) | Revenue Per Share | Quarterly Revenue Growth 2.694 | Return On Assets | Return On Equity |
The market value of Ascendis Pharma AS is measured differently than its book value, which is the value of Ascendis that is recorded on the company's balance sheet. Investors also form their own opinion of Ascendis Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ascendis Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ascendis Pharma's market value can be influenced by many factors that don't directly affect Ascendis Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ascendis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.